Previous Chapter Chapter 24: Intravenous Abuse of Methylphenidate Next Chapter
Chapter 24: Intravenous Abuse of Methylphenidate
Pharmaceutical stimulants such as methylphenidate (MPH) are considered first-line treatment for symptoms of attention deficit/hyperactivity disorder (ADHD). With growing awareness and understanding of ADHD among the public and the medical community, there has been a steady rise in the production and use of these medications worldwide in the last two decades. Much of the increase has been in the form of MPH in different formulations. The bulk of MPH use has been in the USA but other high prescribing countries include Canada, Norway, Netherlands, Israel and Iceland (INCB, 2012, Scheffler et al., 2007).
Since MPH shares pharmacological effects with substances of abuse, such as amphetamine and cocaine, concerns have been raised about its abuse ...